Biotinidase Deficiency in Newborns as Respiratory Distress and Tachypnea: A Case Report
Iranian Journal of Child Neurology,
Vol. 9 No. 2 (2015),
1 April 2015
,
Page 58-60
https://doi.org/10.22037/ijcn.v9i2.6137
Abstract
How to Cite This Article: Kohmanaee Sh, Zarkesh M, Tabrizi M, Hassanzadeh Rad A, Divshali S, Dalili S. Biotinidase Deficiency in Newborns as Respiratory Distress and Tachypnea: A Case Report. Iran J Child Neurol. Spring 2015; 9(2):58-60.
Abstract
Objective
Biotin is a coenzyme composed of four carboxylases. It presents in amino acid catabolism, fatty acid synthesis, and gluconeogenesis. Biotinidase recycles the vitamin biotin. A biotinidase deficiency is a neurocutaneous disorder with autosomal recessive inheritance. The symptoms can be successfully treated
or prevented by administering pharmacological doses of biotin. Although, according to neonatal prenatal medicine (2011), a biotinidase deficiency does not manifest during the neonatal period. In this study, we report on a case of biotinidase deficiency in the first week of birth.
Case Report
A 3100 g term boy was born via cesarean section. After 3 days, he was referred to the 17th Shahrivar Hospital with the chief complaint of tachypnea and grunting.
Laboratory results revealed that liver and renal function tests, serum electrolytes, and blood indexes except ammonia were all normal. Within few days after the administration of oral biotin, the patient showed dramatic improvement and was discharged. However, within 4 months he was admitted two other times with the complaints of diarrhea and pneumonia. Unfortunately, he expired after 4 months.
Conclusion
According to our results, it seems that clinicians should accurately assess suspicious patients and even assess infants for biotinidase deficiency.
- Biotinidase Deficiency
- Biotin
- Newborn
- Children
How to Cite
References
Monnot S, Serre V, Chadefaux‐Vekemans B, Aupetit J, Romano S, De Lonlay P, et al. Structural insights on pathogenic effects of novel mutations causing pyruvate carboxylase deficiency. Human Mutation. 2009;30(5):734-40.
Wolf B. Worldwide survey of neonatal screening for biotinidase deficiency. Journal of inherited metabolic disease. 1991;14(6):923-7.
Wolf B. Biotinidase deficiency:[ldquo] if you have to have an inherited metabolic disease, this is the one to have [rdquo]. Genetics in Medicine. 2012;14(6):565-75.
Thodi G, Schulpis KH, Molou E, Georgiou V, Loukas YL, Dotsikas Y, et al. High incidence of Partial Biotinidase Deficiency cases in newborns of Greek origin. Gene. 2013.
Wolf B, Heard GS, Weissbecker KA, McVoy JRS, Grier RE, Leshner RT. Biotinidase deficiency: initial clinical features and rapid diagnosis. Annals of neurology. 1985;18(5):614-7.
Hymes J, Stanley CM, Wolf B. Mutations in BTD causing biotinidase deficiency. Human mutation. 2001;18(5):375-81.
Zinn A. Inborn error of metabolism. In: Martin RJ FA, Walsh MC, editor. Fanaroff and Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant-Expert Consult.2010; p. 1624-38.
Andersen JB, Blichfeldt S, Christensen MF, Haagerup A. Biotinidase deficiency: two cases of very early presentation. Developmental Medicine & Child Neurology. 1997;39(12):832-5.
Weber P, Scholl S, Baumgartner E. Outcome in patients with profound biotinidase deficiency: relevance of newborn screening. Developmental Medicine & Child Neurology. 2004;46(7):481-4.
Micó SI, Jiménez RD, Salcedo EM, Martínez HA, Mira AP, Fernández CC. Epilepsy in Biotinidase Deficiency After Biotin Treatment. JIMD Reports-Case and Research Reports, 2012/1: Springer; 2012. p. 75-8.
Brunetti-Pierri N, Parenti G, Andria G. Inborn Errors of Metabolism. Neonatology: Springer; 2012. p. 949-66.
Venkataraman V, Balaji P, Panigrahi D, Jamal R. Biotinidase deficiency in childhood. Neurology India. 2013;61(4).
Bunch M, Singh A. Peculiar neuroimaging and electrophysiological findings in a patient with biotinidase deficiency. Seizure. 2011;20(1):83-6.
- Abstract Viewed: 440 times